The amount invested in healthcare companies globally rose to $26.9B in H1’19 compared to $26.5B in H1’18. Over the same period, deals increased from 2,223 to 2,258.
Global Healthcare Report Q2 2019
W HA T I S C B I N S I G H T S ?
CB Insights is a tech market intelligence
platform that analyzes millions of data
points on venture capital, startups, patents,
partnerships, and news mentions to help
you see tomorrow’s opportunities, today.
CLICK HERE TO LEARN MORE
T R U S T E D B Y T H E W O R L D ’ S L E A D I N G C O M P A N I E S
“We use CB Insights to find emerging trends
and interesting companies that might signal a shift in
technology or require us to reallocate resources.”
Beti Cung, Corporate Strategy, Microsoft
October 2-3, 2019
New York, NY
Q2’19 Investment Trends
Quarterly Deals & Dollars
Q2’19 Top VC-Backed Digital Health Deals
Digital Health Unicorns
Q2’19 Healthcare Industry Highlights
Mental Health & Wellness
Most Active Digital Health Investors Q2’19
Hemp/CBD startups take a record 25% of cannabis funding: In Q2'19, 27 (25%) of the
107 cannabis deals were for startups with a hemp and/or CBD business component.
That compares to only 11 (15%) of the 73 deals in Q2’18.
AI in healthcare startups and mental health & wellness startups reach funding highs
in Q2’19: Healthcare AI companies raised $864M in the second quarter, led by a
$200M round to Tempus in May. Mental health & wellness companies raised $321M
across 26 deals, with large rounds going to Quartet and Talkspace.
The application of emerging technologies in genomics is picking up: New platforms
such as telegenomics and blockchain-enabled networks are becoming more prevalent.
Digital therapeutics continue to provide new avenues of treatment for chronic
disease management: This quarter has seen deals going to startups pursuing more
specific health issues such as joint pain and respiratory disorders.
First Round Capital and Jumpstart Foundry participated in the most digital health
rounds in Q2’19: Overlapping tar